New data presented showed that Jardiance® reduced the risk of cardiovascular death compared with placebo when added to standard of...
Read more
Median Technologies, The Imaging Phenomics Company® (ALMDT:PA) is pleased to announce that James Golando, Chief of Operations at Median Technologies...
Read more
Sandoz, a Novartis division and the global leader in biosimilars, announces results from the EQUIRA study. The phase III comparative...
Read more
Adaptive Biotechnologies, a leader in combining next-generation sequencing (NGS) and sophisticated bioinformatics to profile T- and B-cell receptors of the...
Read more
Otsuka Pharmaceutical Co., Ltd. (Otsuka) announced detailed results from the Phase 3 REPRISE trial of tolvaptan, which is under investigation...
Read moreHalozyme Therapeutics, Inc., a biotechnology company developing novel oncology and drug-delivery therapies, today announced that Janssen Biotech, Inc. has initiated...
Read more
Daiichi Sankyo Company, Limited announced that the pivotal phase 3 placebo-controlled ENLIVEN (NCT02371369) study of pexidartinib met its primary endpoint...
Read more
Servier, Pfizer In and Cellectis announced that preliminary results from two phase 1 trials with UCART19, the allogeneic anti-CD19 CAR...
Read moreEisai Co., Ltd. announced that the latest data on its oral dual orexin receptor antagonist lemborexant and its oral beta...
Read moreThe Lupus Research Alliance today announced the first clinical trials to be conducted through its Lupus Clinical Investigators Network (LuCIN)...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
